 | • レポートコード：MRC309Z7925 • 出版社/出版日：GlobalInfoResearch / 2023年9月 • レポート形態：英文、PDF、72ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医薬品＆ヘルスケア |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| GlobalInfoResearchの最新の調査によると、世界の医療用脂肪溶解注射剤の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。 このレポートは、世界の医療用脂肪溶解注射剤市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。 市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。 本レポートの主な目的は次のとおりです。 - 世界および主要国の市場機会の規模を決定するため - 医療用脂肪溶解注射剤の成長可能性を評価するため - 各製品および最終用途市場の将来の成長を予測するため - 市場に影響を与える競争要因を評価するため 医療用脂肪溶解注射剤市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメント ・デオキシコール酸、ホスファチジルコリン、L-カルニチン、ポリペプチド、その他 用途別セグメント ・美容代理店、病院、その他 主要な市場プレーヤー ・AbbVie、Jin Yang Pharmaceutical、Lipo Lab 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、医療用脂肪溶解注射剤製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な医療用脂肪溶解注射剤メーカーの企業概要、2019年～2022年までの医療用脂肪溶解注射剤の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な医療用脂肪溶解注射剤メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2018年～2029年までの地域別医療用脂肪溶解注射剤の販売量、売上、成長性を示しています。 ・第5、6章では、2018年～2029年までの医療用脂肪溶解注射剤の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での医療用脂肪溶解注射剤市場予測を収録しています。 ・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。 ・第13章では、主要な原材料、主要なサプライヤー、および医療用脂肪溶解注射剤の産業チェーンを掲載しています。 ・第14、15章では、医療用脂肪溶解注射剤の販売チャネル、販売業者、顧客、調査結果について説明します。 ***** 目次(一部) ***** ・市場概要 - 医療用脂肪溶解注射剤の概要 - 種類別分析（2018年vs2022年vs2029年）：デオキシコール酸、ホスファチジルコリン、L-カルニチン、ポリペプチド、その他 - 用途別分析（2018年vs2022年vs2029年）：美容代理店、病院、その他 - 世界の医療用脂肪溶解注射剤市場規模・予測 - 世界の医療用脂肪溶解注射剤生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - AbbVie、Jin Yang Pharmaceutical、Lipo Lab ・メーカー別市場シェア・市場集中度 ・地域別市場分析2018年-2029年 ・種類別分析2018年-2029年：デオキシコール酸、ホスファチジルコリン、L-カルニチン、ポリペプチド、その他 ・用途別分析2018年-2029年：美容代理店、病院、その他 ・医療用脂肪溶解注射剤の北米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・医療用脂肪溶解注射剤のヨーロッパ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・医療用脂肪溶解注射剤のアジア市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・医療用脂肪溶解注射剤の南米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・医療用脂肪溶解注射剤の中東・アフリカ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析） ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
According to our (Global Info Research) latest study, the global Medical Injectable Fat Dissolving Products market size was valued at USD 1389.1 million in 2022 and is forecast to a readjusted size of USD 2765.3 million by 2029 with a CAGR of 10.3% during review period.
Injection lipolysis, also known as intralipotherapy, is a minimally invasive medical procedure for targeted fat reduction.
The Global Info Research report includes an overview of the development of the Medical Injectable Fat Dissolving Products industry chain, the market status of Beauty Agency (Deoxycholic acid, Phosphatidylcholine), Hospital (Deoxycholic acid, Phosphatidylcholine), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Medical Injectable Fat Dissolving Products.
Regionally, the report analyzes the Medical Injectable Fat Dissolving Products markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Medical Injectable Fat Dissolving Products market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Medical Injectable Fat Dissolving Products market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Medical Injectable Fat Dissolving Products industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Deoxycholic acid, Phosphatidylcholine).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Medical Injectable Fat Dissolving Products market.
Regional Analysis: The report involves examining the Medical Injectable Fat Dissolving Products market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Medical Injectable Fat Dissolving Products market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Medical Injectable Fat Dissolving Products:
Company Analysis: Report covers individual Medical Injectable Fat Dissolving Products manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Medical Injectable Fat Dissolving Products This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Beauty Agency, Hospital).
Technology Analysis: Report covers specific technologies relevant to Medical Injectable Fat Dissolving Products. It assesses the current state, advancements, and potential future developments in Medical Injectable Fat Dissolving Products areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Medical Injectable Fat Dissolving Products market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Medical Injectable Fat Dissolving Products market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Deoxycholic acid
Phosphatidylcholine
L-carnitine
Polypeptide
Other
Market segment by Application
Beauty Agency
Hospital
Other
Major players covered
AbbVie
Jin Yang Pharmaceutical
Lipo Lab
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Medical Injectable Fat Dissolving Products product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Medical Injectable Fat Dissolving Products, with price, sales, revenue and global market share of Medical Injectable Fat Dissolving Products from 2018 to 2023.
Chapter 3, the Medical Injectable Fat Dissolving Products competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Medical Injectable Fat Dissolving Products breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Medical Injectable Fat Dissolving Products market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Medical Injectable Fat Dissolving Products.
Chapter 14 and 15, to describe Medical Injectable Fat Dissolving Products sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Medical Injectable Fat Dissolving Products
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Medical Injectable Fat Dissolving Products Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Deoxycholic acid
1.3.3 Phosphatidylcholine
1.3.4 L-carnitine
1.3.5 Polypeptide
1.3.6 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Medical Injectable Fat Dissolving Products Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Beauty Agency
1.4.3 Hospital
1.4.4 Other
1.5 Global Medical Injectable Fat Dissolving Products Market Size & Forecast
1.5.1 Global Medical Injectable Fat Dissolving Products Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Medical Injectable Fat Dissolving Products Sales Quantity (2018-2029)
1.5.3 Global Medical Injectable Fat Dissolving Products Average Price (2018-2029)
2 Manufacturers Profiles
2.1 AbbVie
2.1.1 AbbVie Details
2.1.2 AbbVie Major Business
2.1.3 AbbVie Medical Injectable Fat Dissolving Products Product and Services
2.1.4 AbbVie Medical Injectable Fat Dissolving Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 AbbVie Recent Developments/Updates
2.2 Jin Yang Pharmaceutical
2.2.1 Jin Yang Pharmaceutical Details
2.2.2 Jin Yang Pharmaceutical Major Business
2.2.3 Jin Yang Pharmaceutical Medical Injectable Fat Dissolving Products Product and Services
2.2.4 Jin Yang Pharmaceutical Medical Injectable Fat Dissolving Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Jin Yang Pharmaceutical Recent Developments/Updates
2.3 Lipo Lab
2.3.1 Lipo Lab Details
2.3.2 Lipo Lab Major Business
2.3.3 Lipo Lab Medical Injectable Fat Dissolving Products Product and Services
2.3.4 Lipo Lab Medical Injectable Fat Dissolving Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Lipo Lab Recent Developments/Updates
3 Competitive Environment: Medical Injectable Fat Dissolving Products by Manufacturer
3.1 Global Medical Injectable Fat Dissolving Products Sales Quantity by Manufacturer (2018-2023)
3.2 Global Medical Injectable Fat Dissolving Products Revenue by Manufacturer (2018-2023)
3.3 Global Medical Injectable Fat Dissolving Products Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Medical Injectable Fat Dissolving Products by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Medical Injectable Fat Dissolving Products Manufacturer Market Share in 2022
3.4.2 Top 6 Medical Injectable Fat Dissolving Products Manufacturer Market Share in 2022
3.5 Medical Injectable Fat Dissolving Products Market: Overall Company Footprint Analysis
3.5.1 Medical Injectable Fat Dissolving Products Market: Region Footprint
3.5.2 Medical Injectable Fat Dissolving Products Market: Company Product Type Footprint
3.5.3 Medical Injectable Fat Dissolving Products Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Medical Injectable Fat Dissolving Products Market Size by Region
4.1.1 Global Medical Injectable Fat Dissolving Products Sales Quantity by Region (2018-2029)
4.1.2 Global Medical Injectable Fat Dissolving Products Consumption Value by Region (2018-2029)
4.1.3 Global Medical Injectable Fat Dissolving Products Average Price by Region (2018-2029)
4.2 North America Medical Injectable Fat Dissolving Products Consumption Value (2018-2029)
4.3 Europe Medical Injectable Fat Dissolving Products Consumption Value (2018-2029)
4.4 Asia-Pacific Medical Injectable Fat Dissolving Products Consumption Value (2018-2029)
4.5 South America Medical Injectable Fat Dissolving Products Consumption Value (2018-2029)
4.6 Middle East and Africa Medical Injectable Fat Dissolving Products Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Medical Injectable Fat Dissolving Products Sales Quantity by Type (2018-2029)
5.2 Global Medical Injectable Fat Dissolving Products Consumption Value by Type (2018-2029)
5.3 Global Medical Injectable Fat Dissolving Products Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Medical Injectable Fat Dissolving Products Sales Quantity by Application (2018-2029)
6.2 Global Medical Injectable Fat Dissolving Products Consumption Value by Application (2018-2029)
6.3 Global Medical Injectable Fat Dissolving Products Average Price by Application (2018-2029)
7 North America
7.1 North America Medical Injectable Fat Dissolving Products Sales Quantity by Type (2018-2029)
7.2 North America Medical Injectable Fat Dissolving Products Sales Quantity by Application (2018-2029)
7.3 North America Medical Injectable Fat Dissolving Products Market Size by Country
7.3.1 North America Medical Injectable Fat Dissolving Products Sales Quantity by Country (2018-2029)
7.3.2 North America Medical Injectable Fat Dissolving Products Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Medical Injectable Fat Dissolving Products Sales Quantity by Type (2018-2029)
8.2 Europe Medical Injectable Fat Dissolving Products Sales Quantity by Application (2018-2029)
8.3 Europe Medical Injectable Fat Dissolving Products Market Size by Country
8.3.1 Europe Medical Injectable Fat Dissolving Products Sales Quantity by Country (2018-2029)
8.3.2 Europe Medical Injectable Fat Dissolving Products Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Medical Injectable Fat Dissolving Products Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Medical Injectable Fat Dissolving Products Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Medical Injectable Fat Dissolving Products Market Size by Region
9.3.1 Asia-Pacific Medical Injectable Fat Dissolving Products Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Medical Injectable Fat Dissolving Products Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Medical Injectable Fat Dissolving Products Sales Quantity by Type (2018-2029)
10.2 South America Medical Injectable Fat Dissolving Products Sales Quantity by Application (2018-2029)
10.3 South America Medical Injectable Fat Dissolving Products Market Size by Country
10.3.1 South America Medical Injectable Fat Dissolving Products Sales Quantity by Country (2018-2029)
10.3.2 South America Medical Injectable Fat Dissolving Products Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Medical Injectable Fat Dissolving Products Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Medical Injectable Fat Dissolving Products Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Medical Injectable Fat Dissolving Products Market Size by Country
11.3.1 Middle East & Africa Medical Injectable Fat Dissolving Products Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Medical Injectable Fat Dissolving Products Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Medical Injectable Fat Dissolving Products Market Drivers
12.2 Medical Injectable Fat Dissolving Products Market Restraints
12.3 Medical Injectable Fat Dissolving Products Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Medical Injectable Fat Dissolving Products and Key Manufacturers
13.2 Manufacturing Costs Percentage of Medical Injectable Fat Dissolving Products
13.3 Medical Injectable Fat Dissolving Products Production Process
13.4 Medical Injectable Fat Dissolving Products Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Medical Injectable Fat Dissolving Products Typical Distributors
14.3 Medical Injectable Fat Dissolving Products Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
